{
  "id": "ee8c3244f8e3fb53",
  "title": "EYLEA HD\u00ae ( aflibercept ) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases",
  "description": "20260202T131500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/02/tmt-newswire/globenewswire/eylea-hd-aflibercept-injection-8-mg-presentations-at-angiogenesis-2026-underscore-strength-of-its-clinical-profile-for-the-treatment-of-serious-retinal-diseases/2269647",
  "published_at": "20260202T131500Z",
  "fetched_at": "2026-02-03T00:29:56.519436+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/02/tmt-newswire/globenewswire/eylea-hd-aflibercept-injection-8-mg-presentations-at-angiogenesis-2026-underscore-strength-of-its-clinical-profile-for-the-treatment-of-serious-retinal-diseases/2269647",
    "url_mobile": "https://www.manilatimes.net/2026/02/02/tmt-newswire/globenewswire/eylea-hd-aflibercept-injection-8-mg-presentations-at-angiogenesis-2026-underscore-strength-of-its-clinical-profile-for-the-treatment-of-serious-retinal-diseases/2269647/amp",
    "title": "EYLEA HD\u00ae ( aflibercept ) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases",
    "seendate": "20260202T131500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/02/921451.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}